Small cell lung cancer: Difference between revisions

Jump to navigation Jump to search
Line 43: Line 43:
==Treatment==
==Treatment==
[[Small cell carcinoma of the lung medical therapy|Medical therapy]] | [[Small cell carcinoma of the lung surgery|Surgical options]] | [[Small cell carcinoma of the lung primary prevention|Primary prevention]]  | [[Small cell carcinoma of the lung secondary prevention|Secondary prevention]] | [[Small cell carcinoma of the lung cost-effectiveness of therapy|Financial costs]] | [[Small cell carcinoma of the lung future or investigational therapies|Future therapies]]
[[Small cell carcinoma of the lung medical therapy|Medical therapy]] | [[Small cell carcinoma of the lung surgery|Surgical options]] | [[Small cell carcinoma of the lung primary prevention|Primary prevention]]  | [[Small cell carcinoma of the lung secondary prevention|Secondary prevention]] | [[Small cell carcinoma of the lung cost-effectiveness of therapy|Financial costs]] | [[Small cell carcinoma of the lung future or investigational therapies|Future therapies]]
==Prognostic factors==
The pretreatment prognostic factors that consistently predict for prolonged survival include good performance status, female gender, and limited-stage disease. Patients with involvement of the central nervous system or liver at the time of diagnosis have a significantly worse outcome. In general, patients who are confined to bed tolerate aggressive forms of treatment poorly, have increased morbidity, and rarely attain 2-year disease-free survival; however, patients with poor performance status can often derive significant palliative benefit and prolongation of survival from treatment.
Regardless of stage, the current prognosis for patients with SCLC is unsatisfactory even though considerable improvements in diagnosis and therapy have been made during the past 10 to 15 years.


==Related Chapters==
==Related Chapters==

Revision as of 16:59, 9 December 2011

For patient information click here

Template:DiseaseDisorder infobox

Small Cell Carcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Small Cell Carcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Small cell lung cancer On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Small cell lung cancer

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Small cell lung cancer

CDC on Small cell lung cancer

Small cell lung cancer in the news

Blogs on Small cell lung cancer

Directions to Hospitals Treating Small cell carcinoma of the lung

Risk calculators and risk factors for Small cell lung cancer

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and related keywords: Oat Cell Carcinoma, Reserve Cell Carcinoma, Round Cell Carcinoma, Small Cell Lung Carcinoma, Small Cell Lung Cancer


Overview

Historical Perspective

Pathophysiology

Epidemiology and Demographics

Risk Factors

Screening

Causes

Differentiating Small cell carcinoma of the lung from other diseases

Natural history, Complications, & Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics

Treatment

Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies

Related Chapters

External links



Template:WikiDoc Sources